Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

    Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA.

    Diabetes Care. 2009 May;32(5):866-72. Epub 2009 Feb 5.PMID: 19196896 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.

    Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA.

    Diabetes. 2006 Jul;55(7):2001-14. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16804069 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.

    Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R.

    Diabetes. 2006 Dec;55(12):3536-49.PMID: 17130502 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prior feeding alters the response to the 50-g glucose challenge test in pregnancy. The Staub-Traugott effect revisited.

    Lewis GF, McNally C, Blackman JD, Polonsky KS, Barron WM.

    Diabetes Care. 1993 Dec;16(12):1551-6.PMID: 8299450 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

    Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA.

    Diabetes. 1997 Mar;46(3):421-32.PMID: 9032098 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.

    McMahon M, Marsh HM, Rizza RA.

    Diabetes. 1989 Mar;38(3):291-303.PMID: 2492963 [PubMed - indexed for MEDLINE]Related articles

    12.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.

    Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.

    Scand J Clin Lab Invest. 2007;67(3):327-36.PMID: 17454847 [PubMed - indexed for MEDLINE]Related articles

    14.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.

    Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M.

    Diabetes. 2007 May;56(5):1475-80. Epub 2007 Feb 15.PMID: 17303799 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men.

    Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA.

    Diabetes Care. 2007 Aug;30(8):1972-8. Epub 2007 May 11.PMID: 17496236 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.

    Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS.

    Diabetes Care. 1998 Jan;21(1):127-33.PMID: 9538983 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

    Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA.

    J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9.PMID: 11095432 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

    Umpaichitra V, Banerji MA, Castells S.

    J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.PMID: 15270403 [PubMed - indexed for MEDLINE]Related articles

    20.

    Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.

    Calles-Escandon J, Jaspan J, Robbins DC.

    Diabetes Care. 1989 Nov-Dec;12(10):709-14.PMID: 2693010 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data